Tango Therapeutics reported an 82% response rate with vopimetostat plus daraxonrasib in pancreatic cancer and plans a Phase 3 ...

Zai Lab reported an 81.8% response rate for zoci plus atezolizumab in a Phase 1b small cell lung cancer trial and plans a ...

American Express Q3 2026 net income rose to $3.7 billion and EPS increased 31% to $5.42 as the company raised its full-year ...

Rithm Capital reported Q3 2026 net income of $217.1 million, distributable earnings of $315.3 million and a quarterly common ...

Rogers Communications Q3 2026 revenue rose 2% to C$5.443 billion, free cash flow increased 65%, and the company completed its ...

Booz Allen Hamilton reported adjusted EPS of $1.76 in fiscal Q2 2027, beating estimates, while revenue reached $2.78 billion ...

IDEAYA reports a 60.8% response rate and 17.4-month median survival in second-line lung cancer patients treated with IDE849, ...

Zymeworks signs a Roche licensing deal worth up to $813 million for ZW209, including $55 million upfront and potential ...

First Citizens Q3 2026 net income fell to $606 million despite loan and deposit growth, as the bank approved an additional $1 ...

Oil prices rose over 1% as Houthi attacks raised Saudi supply fears, pushing Brent to $114.47 and WTI to $100.84 amid growing ...

Eni Q3 2026 adjusted profit doubled to €2.8 billion, beating forecasts as the energy giant raised its buyback to €3.8 billion ...

Flagstar Q3 2026 common-stockholder income fell to $3 million despite higher net interest income, while credit-loss ...